We’re Chris Gibson u/ShakeNBakeGibson, CEO and co-founder of Recursion Pharmaceuticals, and Imran Haque u/IHaque_Recursion, Recursion’s VP of Data Science. Our company was founded in 2013 by two grad students and a professor looking to take a less biased approach to drug discovery, using tech like AI and robotic automation.

Our work focuses on generating massive amounts of biological and chemical data in-house in our own labs using lots of robots, and use it to train our machine learning algorithms to get better at predicting the result of experiments before we do them! Our drug discovery engine maps biology and chemistry, and helps scientists navigate this map by generating trillions of predicted relationships between genes and chemical compounds. We also release some of this data to the public - we recently deployed our 5th open- source dataset of this information.

We’re all about figuring out how to predict how to treat diseases best! With 5 programs in clinical trials, and dozens more in the works, we’re here and looking forward to answering your questions on drug discovery, AI, data science and more. We'll kick off at 1PM PT / 2PM MT / 4PM ET - Ask us anything!

Proof: Here's my proof

Here's Imran's proof

Edit: Lots of great questions and comments! Our two hours have come to a close. Thank you to everyone who turned out. For more info on MolRec, you can check out the details here. For more info on our open source dataset, RxRx3, you can find that here. You can also catch us over on Twitter, YouTube, or email us at [[email protected]]([email protected]). That’s a wrap, folks!